<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-02-01" modified="2017-05-10" version="210">
<accession>Q05397</accession>
<accession>B4E2N6</accession>
<accession>F5H4S4</accession>
<accession>J3QT16</accession>
<accession>Q14291</accession>
<accession>Q8IYN9</accession>
<accession>Q9UD85</accession>
<name>FAK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Focal adhesion kinase 1</fullName>
<shortName>FADK 1</shortName>
<ecNumber>2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Focal adhesion kinase-related nonkinase</fullName>
<shortName>FRNK</shortName>
</alternativeName>
<alternativeName>
<fullName>Protein phosphatase 1 regulatory subunit 71</fullName>
<shortName>PPP1R71</shortName>
</alternativeName>
<alternativeName>
<fullName>Protein-tyrosine kinase 2</fullName>
</alternativeName>
<alternativeName>
<fullName>p125FAK</fullName>
</alternativeName>
<alternativeName>
<fullName>pp125FAK</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTK2</name>
<name type="synonym">FAK</name>
<name type="synonym">FAK1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="DNA Cell Biol." volume="12" first="823" last="830">
<title>Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK.</title>
<authorList>
<person name="Whitney G.S."/>
<person name="Chan P.Y."/>
<person name="Blake J."/>
<person name="Cosand W.L."/>
<person name="Neubauer M.G."/>
<person name="Aruffo A."/>
<person name="Kanner S.B."/>
</authorList>
<dbReference type="PubMed" id="7692878"/>
<dbReference type="DOI" id="10.1089/dna.1993.12.823"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="190" first="140" last="147">
<title>Expression of an N-terminally truncated form of human focal adhesion kinase in brain.</title>
<authorList>
<person name="Andre E."/>
<person name="Becker-Andre M."/>
</authorList>
<dbReference type="PubMed" id="8422239"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1022"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2007-07" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Glen H."/>
<person name="Brunton V.G."/>
<person name="Frame M.C."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-19; 192-199; 222-236; 243-252; 350-364; 414-419; 468-476; 562-569; 674-690; 798-811; 832-838; 904-933; 963-981; 989-1000 AND 1003-1042</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Osteosarcoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="3403" last="3410">
<title>A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.</title>
<authorList>
<person name="Lee S.-T."/>
<person name="Strunk K.M."/>
<person name="Spritz R.A."/>
</authorList>
<dbReference type="PubMed" id="8247543"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 552-602</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Melanocyte</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="1003" last="1014">
<title>Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions.</title>
<authorList>
<person name="Matsuya M."/>
<person name="Sasaki H."/>
<person name="Aoto H."/>
<person name="Mitaka T."/>
<person name="Nagura K."/>
<person name="Ohba T."/>
<person name="Ishino M."/>
<person name="Takahashi S."/>
<person name="Suzuki R."/>
<person name="Sasaki T."/>
</authorList>
<dbReference type="PubMed" id="9422762"/>
<dbReference type="DOI" id="10.1074/jbc.273.2.1003"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="26516" last="26521">
<title>Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase.</title>
<authorList>
<person name="Fujita H."/>
<person name="Kamiguchi K."/>
<person name="Cho D."/>
<person name="Shibanuma M."/>
<person name="Morimoto C."/>
<person name="Tachibana K."/>
</authorList>
<dbReference type="PubMed" id="9756887"/>
<dbReference type="DOI" id="10.1074/jbc.273.41.26516"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
<scope>MUTAGENESIS OF VAL-928 AND LEU-1034</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="62" last="69">
<title>Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.</title>
<authorList>
<person name="Miao H."/>
<person name="Burnett E."/>
<person name="Kinch M."/>
<person name="Simon E."/>
<person name="Wang B."/>
</authorList>
<dbReference type="PubMed" id="10655584"/>
<dbReference type="DOI" id="10.1038/35000008"/>
</citation>
<scope>FUNCTION IN PXN PHOSPHORYLATION; REGULATION OF CELL SHAPE AND MIGRATION</scope>
<scope>INTERACTION WITH EPHA2</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN11</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Nat. Cell Biol." volume="3" first="439" last="444">
<title>Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain.</title>
<authorList>
<person name="Chen R."/>
<person name="Kim O."/>
<person name="Li M."/>
<person name="Xiong X."/>
<person name="Guan J.L."/>
<person name="Kung H.J."/>
<person name="Chen H."/>
<person name="Shimizu Y."/>
<person name="Qiu Y."/>
</authorList>
<dbReference type="PubMed" id="11331870"/>
<dbReference type="DOI" id="10.1038/35074500"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION AND ACTIVATION OF BMX</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF TYR-397</scope>
<scope>INTERACTION WITH BMX</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="2699" last="2707">
<title>Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples.</title>
<authorList>
<person name="Hecker T.P."/>
<person name="Grammer J.R."/>
<person name="Gillespie G.Y."/>
<person name="Stewart J. Jr."/>
<person name="Gladson C.L."/>
</authorList>
<dbReference type="PubMed" id="11980671"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF SHC1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH SHC1 AND SRC</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="3178" last="3191">
<title>Regulation of focal adhesion kinase by a novel protein inhibitor FIP200.</title>
<authorList>
<person name="Abbi S."/>
<person name="Ueda H."/>
<person name="Zheng C."/>
<person name="Cooper L.A."/>
<person name="Zhao J."/>
<person name="Christopher R."/>
<person name="Guan J.L."/>
</authorList>
<dbReference type="PubMed" id="12221124"/>
<dbReference type="DOI" id="10.1091/mbc.E02-05-0295"/>
</citation>
<scope>INTERACTION WITH RB1CC1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Biochem. J." volume="369" first="407" last="416">
<title>Site-specific phosphorylation of platelet focal adhesion kinase by low-density lipoprotein.</title>
<authorList>
<person name="Relou I.A.M."/>
<person name="Bax L.A.B."/>
<person name="Van Rijn H.J.M."/>
<person name="Akkerman J.-W.N."/>
</authorList>
<dbReference type="PubMed" id="12387730"/>
<dbReference type="DOI" id="10.1042/BJ20020410"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-397; TYR-407; TYR-577; TYR-861 AND TYR-925</scope>
<scope>INTERACTION WITH FGR</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="33024" last="33034">
<title>Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway.</title>
<authorList>
<person name="Xia H."/>
<person name="Nho R.S."/>
<person name="Kahm J."/>
<person name="Kleidon J."/>
<person name="Henke C.A."/>
</authorList>
<dbReference type="PubMed" id="15166238"/>
<dbReference type="DOI" id="10.1074/jbc.M313265200"/>
</citation>
<scope>FUNCTION IN INTEGRIN SIGNALING; REGULATION OF APOPTOSIS; REGULATION OF CELL SHAPE AND ACTIVATION OF PHOSPHATIDYLINOSITOL KINASE AND AKT1 SIGNALING PATHWAY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Exp. Cell Res." volume="302" first="253" last="269">
<title>The proto-oncogene Fgr regulates cell migration and this requires its plasma membrane localization.</title>
<authorList>
<person name="Continolo S."/>
<person name="Baruzzi A."/>
<person name="Majeed M."/>
<person name="Caveggion E."/>
<person name="Fumagalli L."/>
<person name="Lowell C.A."/>
<person name="Berton G."/>
</authorList>
<dbReference type="PubMed" id="15561106"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2004.09.005"/>
</citation>
<scope>FUNCTION IN REGULATION OF CELL MIGRATION</scope>
<scope>PHOSPHORYLATION AT TYR-407; TYR-397 AND TYR-576</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="25008" last="25021">
<title>Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.</title>
<authorList>
<person name="Golubovskaya V.M."/>
<person name="Finch R."/>
<person name="Cance W.G."/>
</authorList>
<dbReference type="PubMed" id="15855171"/>
<dbReference type="DOI" id="10.1074/jbc.M414172200"/>
</citation>
<scope>INTERACTION WITH P53/TP53</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Nat. Cell Biol." volume="7" first="581" last="590">
<title>Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase.</title>
<authorList>
<person name="Ezratty E.J."/>
<person name="Partridge M.A."/>
<person name="Gundersen G.G."/>
</authorList>
<dbReference type="PubMed" id="15895076"/>
<dbReference type="DOI" id="10.1038/ncb1262"/>
</citation>
<scope>FUNCTION IN FOCAL ADHESION DISASSEMBLY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="1446" last="1454">
<title>Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.</title>
<authorList>
<person name="Garces C.A."/>
<person name="Kurenova E.V."/>
<person name="Golubovskaya V.M."/>
<person name="Cance W.G."/>
</authorList>
<dbReference type="PubMed" id="16452200"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-1661"/>
</citation>
<scope>INTERACTION WITH FLT4</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Med. Mol. Morphol." volume="39" first="154" last="160">
<title>Expression of FAK-related non-kinase (FRNK) coincides with morphological change in the early stage of cell adhesion.</title>
<authorList>
<person name="Nagoshi Y."/>
<person name="Yamamoto G."/>
<person name="Irie T."/>
<person name="Tachikawa T."/>
</authorList>
<dbReference type="PubMed" id="16998626"/>
<dbReference type="DOI" id="10.1007/s00795-006-0325-8"/>
</citation>
<scope>ALTERNATIVE PROMOTER USAGE</scope>
<scope>IDENTIFICATION OF ISOFORM 6</scope>
<scope>DEVELOPMENTAL STAGE (ISOFORM 6)</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="10976" last="10983">
<title>Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.</title>
<authorList>
<person name="Halder J."/>
<person name="Lin Y.G."/>
<person name="Merritt W.M."/>
<person name="Spannuth W.A."/>
<person name="Nick A.M."/>
<person name="Honda T."/>
<person name="Kamat A.A."/>
<person name="Han L.Y."/>
<person name="Kim T.J."/>
<person name="Lu C."/>
<person name="Tari A.M."/>
<person name="Bornmann W."/>
<person name="Fernandez A."/>
<person name="Lopez-Berestein G."/>
<person name="Sood A.K."/>
</authorList>
<dbReference type="PubMed" id="18006843"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-2667"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>ROLE IN DISEASE</scope>
<scope>PHOSPHORYLATION AT TYR-397 AND TYR-861</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="14845" last="14852">
<title>Cellular characterization of a novel focal adhesion kinase inhibitor.</title>
<authorList>
<person name="Slack-Davis J.K."/>
<person name="Martin K.H."/>
<person name="Tilghman R.W."/>
<person name="Iwanicki M."/>
<person name="Ung E.J."/>
<person name="Autry C."/>
<person name="Luzzio M.J."/>
<person name="Cooper B."/>
<person name="Kath J.C."/>
<person name="Roberts W.G."/>
<person name="Parsons J.T."/>
</authorList>
<dbReference type="PubMed" id="17395594"/>
<dbReference type="DOI" id="10.1074/jbc.M606695200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>ROLE IN DISEASE</scope>
<scope>PHOSPHORYLATION AT TYR-397</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="J. Cell. Biochem." volume="100" first="499" last="514">
<title>Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5.</title>
<authorList>
<person name="Salasznyk R.M."/>
<person name="Klees R.F."/>
<person name="Boskey A."/>
<person name="Plopper G.E."/>
</authorList>
<dbReference type="PubMed" id="16927379"/>
<dbReference type="DOI" id="10.1002/jcb.21074"/>
</citation>
<scope>FUNCTION IN OSTEOBLAST DIFFERENTIATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Mol. Cancer Ther." volume="6" first="1357" last="1367">
<title>Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo.</title>
<authorList>
<person name="Liu T.J."/>
<person name="LaFortune T."/>
<person name="Honda T."/>
<person name="Ohmori O."/>
<person name="Hatakeyama S."/>
<person name="Meyer T."/>
<person name="Jackson D."/>
<person name="de Groot J."/>
<person name="Yung W.K."/>
</authorList>
<dbReference type="PubMed" id="17431114"/>
<dbReference type="DOI" id="10.1158/1535-7163.MCT-06-0476"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>ROLE IN DISEASE</scope>
<scope>PHOSPHORYLATION AT TYR-397</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Circ. Res." volume="102" first="1502" last="1511">
<title>The LIM protein leupaxin is enriched in smooth muscle and functions as an serum response factor cofactor to induce smooth muscle cell gene transcription.</title>
<authorList>
<person name="Sundberg-Smith L.J."/>
<person name="DiMichele L.A."/>
<person name="Sayers R.L."/>
<person name="Mack C.P."/>
<person name="Taylor J.M."/>
</authorList>
<dbReference type="PubMed" id="18497331"/>
<dbReference type="DOI" id="10.1161/CIRCRESAHA.107.170357"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH LPXN</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Immunol." volume="180" first="3485" last="3491">
<title>Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways.</title>
<authorList>
<person name="Semaan N."/>
<person name="Alsaleh G."/>
<person name="Gottenberg J.E."/>
<person name="Wachsmann D."/>
<person name="Sibilia J."/>
</authorList>
<dbReference type="PubMed" id="18292575"/>
<dbReference type="DOI" id="10.4049/jimmunol.180.5.3485"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BMX</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Mol. Biol. Cell" volume="19" first="1627" last="1636">
<title>A novel Cas family member, HEPL, regulates FAK and cell spreading.</title>
<authorList>
<person name="Singh M.K."/>
<person name="Dadke D."/>
<person name="Nicolas E."/>
<person name="Serebriiskii I.G."/>
<person name="Apostolou S."/>
<person name="Canutescu A."/>
<person name="Egleston B.L."/>
<person name="Golemis E.A."/>
</authorList>
<dbReference type="PubMed" id="18256281"/>
<dbReference type="DOI" id="10.1091/mbc.E07-09-0953"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CASS4</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="9" last="22">
<title>Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.</title>
<authorList>
<person name="Lim S.T."/>
<person name="Chen X.L."/>
<person name="Lim Y."/>
<person name="Hanson D.A."/>
<person name="Vo T.T."/>
<person name="Howerton K."/>
<person name="Larocque N."/>
<person name="Fisher S.J."/>
<person name="Schlaepfer D.D."/>
<person name="Ilic D."/>
</authorList>
<dbReference type="PubMed" id="18206965"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.11.031"/>
</citation>
<scope>FUNCTION IN REGULATION OF P53/TP53 LEVELS; CELL PROLIFERATION AND CELL SURVIVAL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="212" last="221">
<title>Regulation of estrogen rapid signaling through arginine methylation by PRMT1.</title>
<authorList>
<person name="Le Romancer M."/>
<person name="Treilleux I."/>
<person name="Leconte N."/>
<person name="Robin-Lespinasse Y."/>
<person name="Sentis S."/>
<person name="Bouchekioua-Bouzaghou K."/>
<person name="Goddard S."/>
<person name="Gobert-Gosse S."/>
<person name="Corbo L."/>
</authorList>
<dbReference type="PubMed" id="18657504"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.05.025"/>
</citation>
<scope>INTERACTION WITH ESR1; PIK3R1 AND/OR PIK3R2 AND SRC</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-29; SER-887 AND SER-910</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1793" first="781" last="791">
<title>Specific tyrosine phosphorylation of focal adhesion kinase mediated by Fer tyrosine kinase in suspended hepatocytes.</title>
<authorList>
<person name="Oh M.A."/>
<person name="Choi S."/>
<person name="Lee M.J."/>
<person name="Choi M.C."/>
<person name="Lee S.A."/>
<person name="Ko W."/>
<person name="Cance W.G."/>
<person name="Oh E.S."/>
<person name="Buday L."/>
<person name="Kim S.H."/>
<person name="Lee J.W."/>
</authorList>
<dbReference type="PubMed" id="19339212"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2009.01.015"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-397; TYR-576; TYR-577; SER-722; TYR-861 AND TYR-925</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH CTTN AND FER</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="BMC Cancer" volume="9" first="12" last="12">
<title>Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.</title>
<authorList>
<person name="Sachdev S."/>
<person name="Bu Y."/>
<person name="Gelman I.H."/>
</authorList>
<dbReference type="PubMed" id="19138410"/>
<dbReference type="DOI" id="10.1186/1471-2407-9-12"/>
</citation>
<scope>FUNCTION IN SRC-MEDIATED PHOSPHORYLATION OF PXN</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Int. J. Mol. Med." volume="24" first="599" last="604">
<title>STEAP4 regulates focal adhesion kinase activation and CpG motifs within STEAP4 promoter region are frequently methylated in DU145, human androgen-independent prostate cancer cells.</title>
<authorList>
<person name="Tamura T."/>
<person name="Chiba J."/>
</authorList>
<dbReference type="PubMed" id="19787193"/>
<dbReference type="DOI" id="10.3892/ijmm_00000270"/>
</citation>
<scope>INTERACTION WITH STEAP4</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Invest. Ophthalmol. Vis. Sci." volume="50" first="4949" last="4956">
<title>Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2).</title>
<authorList>
<person name="Morales S.A."/>
<person name="Mareninov S."/>
<person name="Coulam P."/>
<person name="Wadehra M."/>
<person name="Goodglick L."/>
<person name="Braun J."/>
<person name="Gordon L.K."/>
</authorList>
<dbReference type="PubMed" id="19494199"/>
<dbReference type="DOI" id="10.1167/iovs.08-3315"/>
</citation>
<scope>INTERACTION WITH EMP2</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="J. Clin. Invest." volume="119" first="252" last="266">
<title>Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.</title>
<authorList>
<person name="Pylayeva Y."/>
<person name="Gillen K.M."/>
<person name="Gerald W."/>
<person name="Beggs H.E."/>
<person name="Reichardt L.F."/>
<person name="Giancotti F.G."/>
</authorList>
<dbReference type="PubMed" id="19147981"/>
<dbReference type="DOI" id="10.1172/JCI37160"/>
</citation>
<scope>FUNCTION IN SRC-MEDIATED PHOSPHORYLATION OF BCAR1</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="243" last="255">
<title>EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility.</title>
<authorList>
<person name="Yamazaki T."/>
<person name="Masuda J."/>
<person name="Omori T."/>
<person name="Usui R."/>
<person name="Akiyama H."/>
<person name="Maru Y."/>
</authorList>
<dbReference type="PubMed" id="19118217"/>
<dbReference type="DOI" id="10.1242/jcs.036467"/>
</citation>
<scope>INTERACTION WITH EPHA1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-5; THR-13; SER-29; TYR-397; TYR-570; SER-580 AND SER-910</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Cancer Biol. Ther." volume="10" first="38" last="43">
<title>Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models.</title>
<authorList>
<person name="Sun H."/>
<person name="Pisle S."/>
<person name="Gardner E.R."/>
<person name="Figg W.D."/>
</authorList>
<dbReference type="PubMed" id="20495381"/>
<dbReference type="DOI" id="10.4161/cbt.10.1.11993"/>
</citation>
<scope>ROLE IN DISEASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="Cancer Sci." volume="101" first="363" last="368">
<title>LIM domain-containing adaptor, leupaxin, localizes in focal adhesion and suppresses the integrin-induced tyrosine phosphorylation of paxillin.</title>
<authorList>
<person name="Tanaka T."/>
<person name="Moriwaki K."/>
<person name="Murata S."/>
<person name="Miyasaka M."/>
</authorList>
<dbReference type="PubMed" id="19917054"/>
<dbReference type="DOI" id="10.1111/j.1349-7006.2009.01398.x"/>
</citation>
<scope>INTERACTION WITH LPXN</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Exp. Cell Res." volume="316" first="1600" last="1609">
<title>Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts.</title>
<authorList>
<person name="Cai G.Q."/>
<person name="Zheng A."/>
<person name="Tang Q."/>
<person name="White E.S."/>
<person name="Chou C.F."/>
<person name="Gladson C.L."/>
<person name="Olman M.A."/>
<person name="Ding Q."/>
</authorList>
<dbReference type="PubMed" id="20109444"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2010.01.021"/>
</citation>
<scope>FUNCTION (ISOFORM 6)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="21013" last="21022">
<title>ZF21 protein regulates cell adhesion and motility.</title>
<authorList>
<person name="Nagano M."/>
<person name="Hoshino D."/>
<person name="Sakamoto T."/>
<person name="Kawasaki N."/>
<person name="Koshikawa N."/>
<person name="Seiki M."/>
</authorList>
<dbReference type="PubMed" id="20439989"/>
<dbReference type="DOI" id="10.1074/jbc.M110.106443"/>
</citation>
<scope>INTERACTION WITH ZFYVE21</scope>
<scope>DEPHOSPHORYLATION AT TYR-397</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="155" last="161">
<title>CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.</title>
<authorList>
<person name="Stewart C.R."/>
<person name="Stuart L.M."/>
<person name="Wilkinson K."/>
<person name="van Gils J.M."/>
<person name="Deng J."/>
<person name="Halle A."/>
<person name="Rayner K.J."/>
<person name="Boyer L."/>
<person name="Zhong R."/>
<person name="Frazier W.A."/>
<person name="Lacy-Hulbert A."/>
<person name="El Khoury J."/>
<person name="Golenbock D.T."/>
<person name="Moore K.J."/>
</authorList>
<dbReference type="PubMed" id="20037584"/>
<dbReference type="DOI" id="10.1038/ni.1836"/>
</citation>
<scope>INTERACTION WITH CD36</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910 AND THR-914</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="17292" last="17302">
<title>Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.</title>
<authorList>
<person name="Plaza-Menacho I."/>
<person name="Morandi A."/>
<person name="Mologni L."/>
<person name="Boender P."/>
<person name="Gambacorti-Passerini C."/>
<person name="Magee A.I."/>
<person name="Hofstra R.M.W."/>
<person name="Knowles P."/>
<person name="McDonald N.Q."/>
<person name="Isacke C.M."/>
</authorList>
<dbReference type="PubMed" id="21454698"/>
<dbReference type="DOI" id="10.1074/jbc.M110.168500"/>
</citation>
<scope>INTERACTION WITH RET</scope>
<scope>FUNCTION IN RET PHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT TYR-576 AND TYR-577</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-29; SER-843 AND SER-910</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="1167" last="1180">
<title>A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis.</title>
<authorList>
<person name="Armacki M."/>
<person name="Joodi G."/>
<person name="Nimmagadda S.C."/>
<person name="de Kimpe L."/>
<person name="Pusapati G.V."/>
<person name="Vandoninck S."/>
<person name="Van Lint J."/>
<person name="Illing A."/>
<person name="Seufferlein T."/>
</authorList>
<dbReference type="PubMed" id="23503467"/>
<dbReference type="DOI" id="10.1038/onc.2013.43"/>
</citation>
<scope>INTERACTION WITH CIB1 ISOFORM 2</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="52">
<citation type="journal article" date="1999" name="Prog. Biophys. Mol. Biol." volume="71" first="435" last="478">
<title>Signaling through focal adhesion kinase.</title>
<authorList>
<person name="Schlaepfer D.D."/>
<person name="Hauck C.R."/>
<person name="Sieg D.J."/>
</authorList>
<dbReference type="PubMed" id="10354709"/>
<dbReference type="DOI" id="10.1016/S0079-6107(98)00052-2"/>
</citation>
<scope>REVIEW ON SIGNALING AND ON DIRECT PTK2/FAK1 SUBSTRATES</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2005" name="Cell Cycle" volume="4" first="E131" last="E135">
<title>Netrin-integrin signaling in epithelial morphogenesis, axon guidance and vascular patterning.</title>
<authorList>
<person name="Nikolopoulos S.N."/>
<person name="Giancotti F.G."/>
</authorList>
<dbReference type="PubMed" id="15725728"/>
</citation>
<scope>REVIEW ON FUNCTION IN NETRIN SIGNALING</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2006" name="Curr. Opin. Cell Biol." volume="18" first="516" last="523">
<title>Integrin-regulated FAK-Src signaling in normal and cancer cells.</title>
<authorList>
<person name="Mitra S.K."/>
<person name="Schlaepfer D.D."/>
</authorList>
<dbReference type="PubMed" id="16919435"/>
<dbReference type="DOI" id="10.1016/j.ceb.2006.08.011"/>
</citation>
<scope>REVIEW ON FUNCTION IN CELL MIGRATION; FOCAL ADHESION TURNOVER AND ACTIVATION OF SIGNALING PATHWAYS</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2007" name="IUBMB Life" volume="59" first="709" last="716">
<title>Focal adhesion kinase: an essential kinase in the regulation of cardiovascular functions.</title>
<authorList>
<person name="Vadali K."/>
<person name="Cai X."/>
<person name="Schaller M.D."/>
</authorList>
<dbReference type="PubMed" id="17968709"/>
<dbReference type="DOI" id="10.1080/15216540701694245"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="2306" last="2314">
<title>FERM control of FAK function: implications for cancer therapy.</title>
<authorList>
<person name="Lim S.T."/>
<person name="Mikolon D."/>
<person name="Stupack D.G."/>
<person name="Schlaepfer D.D."/>
</authorList>
<dbReference type="PubMed" id="18677107"/>
<dbReference type="DOI" id="10.4161/cc.6367"/>
</citation>
<scope>REVIEW ON ROLE IN INTEGRIN SIGNALING AND IN REGULATION OF P53/TP53 ACTIVITIES</scope>
<scope>ROLE IN DISEASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2009" name="Curr. Opin. Cell Biol." volume="21" first="676" last="683">
<title>Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility.</title>
<authorList>
<person name="Tomar A."/>
<person name="Schlaepfer D.D."/>
</authorList>
<dbReference type="PubMed" id="19525103"/>
<dbReference type="DOI" id="10.1016/j.ceb.2009.05.006"/>
</citation>
<scope>REVIEW ON FUNCTION IN REGULATION OF RHO FAMILY GTPASE ACTIVITY</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2009" name="Histol. Histopathol." volume="24" first="503" last="510">
<title>Focal adhesion kinase and cancer.</title>
<authorList>
<person name="Golubovskaya V.M."/>
<person name="Kweh F.A."/>
<person name="Cance W.G."/>
</authorList>
<dbReference type="PubMed" id="19224453"/>
<dbReference type="DOI" id="10.14670/HH-24.503"/>
</citation>
<scope>REVIEW ON EXPRESSION IN CANCER</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2010" name="Front. Biosci." volume="15" first="901" last="912">
<title>Focal adhesion kinase and p53 signal transduction pathways in cancer.</title>
<authorList>
<person name="Golubovskaya V.M."/>
<person name="Cance W."/>
</authorList>
<dbReference type="PubMed" id="20515733"/>
<dbReference type="DOI" id="10.2741/3653"/>
</citation>
<scope>REVIEW ON FUNCTION IN REGULATION OF P53/TP53</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2010" name="Histol. Histopathol." volume="25" first="1039" last="1055">
<title>The role of focal adhesion kinase in early development.</title>
<authorList>
<person name="Chatzizacharias N.A."/>
<person name="Kouraklis G.P."/>
<person name="Theocharis S.E."/>
</authorList>
<dbReference type="PubMed" id="20552554"/>
<dbReference type="DOI" id="10.14670/HH-25.1039"/>
</citation>
<scope>REVIEW ON ROLE IN DEVELOPMENT</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2010" name="IUBMB Life" volume="62" first="268" last="276">
<title>Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer.</title>
<authorList>
<person name="Guan J.L."/>
</authorList>
<dbReference type="PubMed" id="20101634"/>
<dbReference type="DOI" id="10.1002/iub.303"/>
</citation>
<scope>REVIEW ON FUNCTION IN INTEGRIN SIGNALING AND ACTIVATION OF DOWNSTREAM SIGNALING PATHWAYS</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="1007" last="1013">
<title>Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions.</title>
<authorList>
<person name="Schaller M.D."/>
</authorList>
<dbReference type="PubMed" id="20332118"/>
<dbReference type="DOI" id="10.1242/jcs.045112"/>
</citation>
<scope>FUNCTION</scope>
<scope>SIGNALING</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2011" name="Int. Rev. Cell Mol. Biol." volume="288" first="185" last="225">
<title>Focal adhesion kinase: exploring Fak structure to gain insight into function.</title>
<authorList>
<person name="Hall J.E."/>
<person name="Fu W."/>
<person name="Schaller M.D."/>
</authorList>
<dbReference type="PubMed" id="21482413"/>
<dbReference type="DOI" id="10.1016/B978-0-12-386041-5.00005-4"/>
</citation>
<scope>REVIEW ON FUNCTION; SUBUNIT; PHOSPHORYLATION; ENZYME REGULATION AND ROLE IN DISEASE</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2013" name="J. Cell Biol." volume="200" first="773" last="787">
<title>MISP is a novel Plk1 substrate required for proper spindle orientation and mitotic progression.</title>
<authorList>
<person name="Zhu M."/>
<person name="Settele F."/>
<person name="Kotak S."/>
<person name="Sanchez-Pulido L."/>
<person name="Ehret L."/>
<person name="Ponting C.P."/>
<person name="Goenczy P."/>
<person name="Hoffmann I."/>
</authorList>
<dbReference type="PubMed" id="23509069"/>
<dbReference type="DOI" id="10.1083/jcb.201207050"/>
</citation>
<scope>INTERACTION WITH MISP</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2002" name="Structure" volume="10" first="319" last="327">
<title>The structural basis of localization and signaling by the focal adhesion targeting domain.</title>
<authorList>
<person name="Arold S.T."/>
<person name="Hoellerer M.K."/>
<person name="Noble M.E."/>
</authorList>
<dbReference type="PubMed" id="12005431"/>
<dbReference type="DOI" id="10.1016/S0969-2126(02)00717-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 891-1052</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2002" name="Structure" volume="10" first="1659" last="1667">
<title>Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography.</title>
<authorList>
<person name="Nowakowski J."/>
<person name="Cronin C.N."/>
<person name="McRee D.E."/>
<person name="Knuth M.W."/>
<person name="Nelson C.G."/>
<person name="Pavletich N.P."/>
<person name="Rogers J."/>
<person name="Sang B.C."/>
<person name="Scheibe D.N."/>
<person name="Swanson R.V."/>
<person name="Thompson D.A."/>
</authorList>
<dbReference type="PubMed" id="12467573"/>
<dbReference type="DOI" id="10.1016/S0969-2126(02)00907-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 411-686 IN COMPLEX WITH ATP</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2003" name="Structure" volume="11" first="1207" last="1217">
<title>Molecular recognition of paxillin LD motifs by the focal adhesion targeting domain.</title>
<authorList>
<person name="Hoellerer M.K."/>
<person name="Noble M.E."/>
<person name="Labesse G."/>
<person name="Campbell I.D."/>
<person name="Werner J.M."/>
<person name="Arold S.T."/>
</authorList>
<dbReference type="PubMed" id="14527389"/>
<dbReference type="DOI" id="10.1016/j.str.2003.08.010"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 892-1052 IN COMPLEX WITH PXN</scope>
<scope>INTERACTION WITH PXN</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="1935" last="1944">
<title>Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.</title>
<authorList>
<person name="Roberts W.G."/>
<person name="Ung E."/>
<person name="Whalen P."/>
<person name="Cooper B."/>
<person name="Hulford C."/>
<person name="Autry C."/>
<person name="Richter D."/>
<person name="Emerson E."/>
<person name="Lin J."/>
<person name="Kath J."/>
<person name="Coleman K."/>
<person name="Yao L."/>
<person name="Martinez-Alsina L."/>
<person name="Lorenzen M."/>
<person name="Berliner M."/>
<person name="Luzzio M."/>
<person name="Patel N."/>
<person name="Schmitt E."/>
<person name="LaGreca S."/>
<person name="Jani J."/>
<person name="Wessel M."/>
<person name="Marr E."/>
<person name="Griffor M."/>
<person name="Vajdos F."/>
</authorList>
<dbReference type="PubMed" id="18339875"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-5155"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 414-689 IN COMPLEX WITH INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="375" first="1320" last="1328">
<title>Structural basis for the interaction between focal adhesion kinase and CD4.</title>
<authorList>
<person name="Garron M.L."/>
<person name="Arthos J."/>
<person name="Guichou J.F."/>
<person name="McNally J."/>
<person name="Cicala C."/>
<person name="Arold S.T."/>
</authorList>
<dbReference type="PubMed" id="18078954"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.11.040"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.82 ANGSTROMS) OF 891-1052 IN COMPLEX WITH CD4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CD4</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] PRO-292; GLN-292; ALA-793; GLU-1030 AND GLU-1044</scope>
</reference>
<comment type="function">
<text evidence="19 20 21 26 27 29 31 32 34 35 36 37 39 40 41 43 45 47 48 49 56 58 59">Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse formation; required for normal development of the nervous system. Plays a role in osteogenesis and differentiation of osteoblasts. Functions in integrin signal transduction, but also in signaling downstream of numerous growth factor receptors, G-protein coupled receptors (GPCR), EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling cascade. Promotes localized and transient activation of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), and thereby modulates the activity of Rho family GTPases. Signaling via CAS family members mediates activation of RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes phosphorylation of PXN and STAT1; most likely PXN and STAT1 are phosphorylated by a SRC family kinase that is recruited to autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1. Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription.</text>
</comment>
<comment type="catalytic activity">
<text evidence="18 19 20 42">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="19 34 35 37 45 58">Subject to autoinhibition, mediated by interactions between the FERM domain and the kinase domain. Activated by autophosphorylation at Tyr-397. This promotes interaction with SRC and phosphorylation at Tyr-576 and Tyr-577 in the kinase activation loop. Phosphorylation at Tyr-576 and Tyr-577 is required for maximal kinase activity. Inhibited by TAC544, TAE226, PF-573,228 and PF-562,271.</text>
</comment>
<comment type="subunit">
<text evidence="14 19 20 21 22 23 24 25 28 30 38 40 41 42 43 44 46 50 51 52 53 54 57 59 60 61 65 66">Interacts (via first Pro-rich region) with CAS family members (via SH3 domain), including BCAR1, BCAR3, CASS4 and NEDD9. Interacts with GIT1. Interacts with SORBS1. Interacts with ARHGEF28. Interacts with SHB. Interacts with PXN and TLN1. Interacts with STAT1. Interacts with DCC. Interacts with WASL. Interacts with ARHGEF7. Interacts with GRB2 and GRB7 (By similarity). Component of a complex that contains at least FER, CTTN and PTK2/FAK1. Interacts with BMX. Interacts with TGFB1I1. Interacts with STEAP4. Interacts with ZFYVE21. Interacts with ESR1. Interacts with PIK3R1 or PIK3R2. Interacts with SRC, FGR, FLT4 and RET. Interacts with EPHA2 in resting cells; activation of EPHA2 recruits PTPN11, leading to dephosphorylation of PTK2/FAK1 and dissociation of the complex. Interacts with EPHA1 (kinase activity-dependent). Interacts with CD4; this interaction requires the presence of HIV-1 gp120. Interacts with PIAS1. Interacts with ARHGAP26 and SHC1. Interacts with RB1CC1; this inhibits PTK2/FAK1 activity and activation of downstream signaling pathways. Interacts with P53/TP53 and MDM2. Interacts with LPXN (via LD motif 3). Interacts with MISP. Interacts with CIB1 isoform 2. Interacts with CD36. Interacts with EMP2; regulates PTK2 activation and localization (PubMed:19494199).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-702093">
<id>P56945</id>
<label>BCAR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-702104">
<id>P29317</id>
<label>EPHA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-1026718">
<id>P17948</id>
<label>FLT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-9834454">
<id>P08631-2</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-948678">
<id>P16144</id>
<label>ITGB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-724478">
<id>Q9H3S7</id>
<label>PTPN23</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-7399369">
<id>P29350-3</id>
<label>PTPN6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-1056751">
<id>Q9Y3E5</id>
<label>PTRH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-702209">
<id>P49023</id>
<label>PXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-298680">
<id>P05480</id>
<label>Src</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-1051449">
<id>O43294</id>
<label>TGFB1I1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-642844">
<id>Q62219</id>
<label>Tgfb1i1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702142"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell junction</location>
<location>Focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Peripheral membrane protein</topology>
<orientation>Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cell cortex</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cytoplasm</location>
<location evidence="14">Cytoskeleton</location>
<location evidence="14">Microtubule organizing center</location>
<location evidence="14">Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Constituent of focal adhesions. Detected at microtubules.</text>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<event type="alternative splicing"/>
<isoform>
<id>Q05397-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q05397-2</id>
<name>2</name>
<sequence type="described" ref="VSP_004967 VSP_004968 VSP_004969 VSP_004970"/>
</isoform>
<isoform>
<id>Q05397-3</id>
<name>3</name>
<sequence type="described" ref="VSP_004967 VSP_004968 VSP_004969 VSP_004973 VSP_004974"/>
</isoform>
<isoform>
<id>Q05397-4</id>
<name>4</name>
<sequence type="described" ref="VSP_004967 VSP_004968 VSP_004969 VSP_004971 VSP_004972"/>
</isoform>
<isoform>
<id>Q05397-5</id>
<name>5</name>
<sequence type="described" ref="VSP_042169 VSP_042170"/>
</isoform>
<isoform>
<id>Q05397-6</id>
<name>6</name>
<name>FRNK</name>
<sequence type="described" ref="VSP_042168"/>
<text>Produced by alternative promoter usage.</text>
</isoform>
<isoform>
<id>Q05397-7</id>
<name>7</name>
<sequence type="described" ref="VSP_057268"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="55 62 63 64">Detected in B and T-lymphocytes. Isoform 1 and isoform 6 are detected in lung fibroblasts (at protein level). Ubiquitous.</text>
</comment>
<comment type="developmental stage">
<text>Isoform 6 is detected in cultured cells, immediately after seeding and before formation of focal adhesions (at protein level).</text>
</comment>
<comment type="domain">
<text>The Pro-rich regions interact with the SH3 domain of CAS family members, such as BCAR1 and NEDD9, and with the GTPase activating protein ARHGAP26.</text>
</comment>
<comment type="domain">
<text>The carboxy-terminal region is the site of focal adhesion targeting (FAT) sequence which mediates the localization of FAK1 to focal adhesions.</text>
</comment>
<comment type="PTM">
<text evidence="23 27 34 35 37 50 59">Phosphorylated on tyrosine residues upon activation, e.g. upon integrin signaling. Tyr-397 is the major autophosphorylation site, but other kinases can also phosphorylate this residue. Phosphorylation at Tyr-397 promotes interaction with SRC and SRC family members, leading to phosphorylation at Tyr-576, Tyr-577 and at additional tyrosine residues. FGR promotes phosphorylation at Tyr-397 and Tyr-576. FER promotes phosphorylation at Tyr-577, Tyr-861 and Tyr-925, even when cells are not adherent. Tyr-397, Tyr-576 and Ser-722 are phosphorylated only when cells are adherent. Phosphorylation at Tyr-397 is important for interaction with BMX, PIK3R1 and SHC1. Phosphorylation at Tyr-925 is important for interaction with GRB2. Dephosphorylated by PTPN11; PTPN11 is recruited to PTK2 via EPHA2 (tyrosine phosphorylated). Microtubule-induced dephosphorylation at Tyr-397 is crucial for the induction of focal adhesion disassembly; this dephosphorylation could be catalyzed by PTPN11 and regulated by ZFYVE21.</text>
</comment>
<comment type="PTM">
<text evidence="14">Sumoylated; this enhances autophosphorylation.</text>
</comment>
<comment type="disease">
<text>Aberrant PTK2/FAK1 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. PTK2/FAK1 overexpression is seen in many types of cancer.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the protein kinase superfamily. Tyr protein kinase family. FAK subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PTK2ID41898ch8q24.html"/>
</comment>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="L13616">
<property type="protein sequence ID" value="AAA58469.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L05186">
<property type="protein sequence ID" value="AAA35819.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304356">
<property type="protein sequence ID" value="BAG65198.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC067931">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC100860">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC105009">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC105235">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="KF458878">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="KF458882">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC035404">
<property type="protein sequence ID" value="AAH35404.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56557.1">
<molecule id="Q05397-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6381.1">
<molecule id="Q05397-1"/>
</dbReference>
<dbReference type="PIR" id="I53012">
<property type="entry name" value="I53012"/>
</dbReference>
<dbReference type="PIR" id="PC1225">
<property type="entry name" value="PC1225"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186578.1">
<molecule id="Q05397-5"/>
<property type="nucleotide sequence ID" value="NM_001199649.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_722560.1">
<molecule id="Q05397-1"/>
<property type="nucleotide sequence ID" value="NM_153831.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869162.1">
<molecule id="Q05397-1"/>
<property type="nucleotide sequence ID" value="XM_017013673.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.395482"/>
<dbReference type="PDB" id="1K04">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=891-1052"/>
</dbReference>
<dbReference type="PDB" id="1K05">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C=891-1052"/>
</dbReference>
<dbReference type="PDB" id="1MP8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=411-686"/>
</dbReference>
<dbReference type="PDB" id="1OW6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B/C=892-1052"/>
</dbReference>
<dbReference type="PDB" id="1OW7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C=892-1052"/>
</dbReference>
<dbReference type="PDB" id="1OW8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B/C=892-1052"/>
</dbReference>
<dbReference type="PDB" id="2ETM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=411-689"/>
</dbReference>
<dbReference type="PDB" id="2IJM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A/B=411-689"/>
</dbReference>
<dbReference type="PDB" id="3B71">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="A/B/C=891-1052"/>
</dbReference>
<dbReference type="PDB" id="3BZ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=414-689"/>
</dbReference>
<dbReference type="PDB" id="3PXK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A/B=411-689"/>
</dbReference>
<dbReference type="PDB" id="3S9O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C=891-1052"/>
</dbReference>
<dbReference type="PDB" id="4EBV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.67"/>
<property type="chains" value="A=411-686"/>
</dbReference>
<dbReference type="PDB" id="4EBW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=411-686"/>
</dbReference>
<dbReference type="PDB" id="4GU6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=411-689"/>
</dbReference>
<dbReference type="PDB" id="4GU9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=410-686"/>
</dbReference>
<dbReference type="PDB" id="4I4E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=411-686"/>
</dbReference>
<dbReference type="PDB" id="4I4F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=411-686"/>
</dbReference>
<dbReference type="PDB" id="4K8A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.91"/>
<property type="chains" value="A/B=410-686"/>
</dbReference>
<dbReference type="PDB" id="4K9Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=410-686"/>
</dbReference>
<dbReference type="PDB" id="4KAB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A/B=410-686"/>
</dbReference>
<dbReference type="PDB" id="4KAO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A/B=410-689"/>
</dbReference>
<dbReference type="PDB" id="4NY0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D=31-405"/>
</dbReference>
<dbReference type="PDB" id="4Q9S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A=411-686"/>
</dbReference>
<dbReference type="PDBsum" id="1K04"/>
<dbReference type="PDBsum" id="1K05"/>
<dbReference type="PDBsum" id="1MP8"/>
<dbReference type="PDBsum" id="1OW6"/>
<dbReference type="PDBsum" id="1OW7"/>
<dbReference type="PDBsum" id="1OW8"/>
<dbReference type="PDBsum" id="2ETM"/>
<dbReference type="PDBsum" id="2IJM"/>
<dbReference type="PDBsum" id="3B71"/>
<dbReference type="PDBsum" id="3BZ3"/>
<dbReference type="PDBsum" id="3PXK"/>
<dbReference type="PDBsum" id="3S9O"/>
<dbReference type="PDBsum" id="4EBV"/>
<dbReference type="PDBsum" id="4EBW"/>
<dbReference type="PDBsum" id="4GU6"/>
<dbReference type="PDBsum" id="4GU9"/>
<dbReference type="PDBsum" id="4I4E"/>
<dbReference type="PDBsum" id="4I4F"/>
<dbReference type="PDBsum" id="4K8A"/>
<dbReference type="PDBsum" id="4K9Y"/>
<dbReference type="PDBsum" id="4KAB"/>
<dbReference type="PDBsum" id="4KAO"/>
<dbReference type="PDBsum" id="4NY0"/>
<dbReference type="PDBsum" id="4Q9S"/>
<dbReference type="ProteinModelPortal" id="Q05397"/>
<dbReference type="SMR" id="Q05397"/>
<dbReference type="BioGrid" id="111719">
<property type="interactions" value="120"/>
</dbReference>
<dbReference type="IntAct" id="Q05397">
<property type="interactions" value="69"/>
</dbReference>
<dbReference type="MINT" id="MINT-92695"/>
<dbReference type="STRING" id="9606.ENSP00000341189"/>
<dbReference type="BindingDB" id="Q05397"/>
<dbReference type="ChEMBL" id="CHEMBL2695"/>
<dbReference type="DrugBank" id="DB07460">
<property type="generic name" value="2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2180"/>
<dbReference type="iPTMnet" id="Q05397"/>
<dbReference type="PhosphoSitePlus" id="Q05397"/>
<dbReference type="BioMuta" id="PTK2"/>
<dbReference type="DMDM" id="3183518"/>
<dbReference type="EPD" id="Q05397"/>
<dbReference type="MaxQB" id="Q05397"/>
<dbReference type="PaxDb" id="Q05397"/>
<dbReference type="PeptideAtlas" id="Q05397"/>
<dbReference type="PRIDE" id="Q05397"/>
<dbReference type="DNASU" id="5747"/>
<dbReference type="Ensembl" id="ENST00000340930">
<molecule id="Q05397-5"/>
<property type="protein sequence ID" value="ENSP00000341189"/>
<property type="gene ID" value="ENSG00000169398"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395218">
<molecule id="Q05397-7"/>
<property type="protein sequence ID" value="ENSP00000378644"/>
<property type="gene ID" value="ENSG00000169398"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000521059">
<molecule id="Q05397-1"/>
<property type="protein sequence ID" value="ENSP00000429474"/>
<property type="gene ID" value="ENSG00000169398"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000522684">
<molecule id="Q05397-1"/>
<property type="protein sequence ID" value="ENSP00000429911"/>
<property type="gene ID" value="ENSG00000169398"/>
</dbReference>
<dbReference type="GeneID" id="5747"/>
<dbReference type="KEGG" id="hsa:5747"/>
<dbReference type="UCSC" id="uc003yvu.4">
<molecule id="Q05397-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5747"/>
<dbReference type="DisGeNET" id="5747"/>
<dbReference type="GeneCards" id="PTK2"/>
<dbReference type="HGNC" id="HGNC:9611">
<property type="gene designation" value="PTK2"/>
</dbReference>
<dbReference type="HPA" id="CAB004036"/>
<dbReference type="HPA" id="HPA001842"/>
<dbReference type="HPA" id="HPA029671"/>
<dbReference type="MIM" id="600758">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q05397"/>
<dbReference type="OpenTargets" id="ENSG00000169398"/>
<dbReference type="PharmGKB" id="PA33955"/>
<dbReference type="eggNOG" id="KOG4257">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZH9Y">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000069938"/>
<dbReference type="HOVERGEN" id="HBG004018"/>
<dbReference type="InParanoid" id="Q05397"/>
<dbReference type="KO" id="K05725"/>
<dbReference type="PhylomeDB" id="Q05397"/>
<dbReference type="TreeFam" id="TF316643"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111465">
<property type="pathway name" value="Apoptotic cleavage of cellular proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029482">
<property type="pathway name" value="Regulation of actin dynamics for phagocytic cup formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-354192">
<property type="pathway name" value="Integrin alphaIIb beta3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-354194">
<property type="pathway name" value="GRB2:SOS provides linkage to MAPK signaling for Integrins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-372708">
<property type="pathway name" value="p130Cas linkage to MAPK signaling for integrins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-375165">
<property type="pathway name" value="NCAM signaling for neurite out-growth"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-391160">
<property type="pathway name" value="Signal regulatory protein (SIRP) family interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928662">
<property type="pathway name" value="EPHB-mediated forward signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928663">
<property type="pathway name" value="EPHA-mediated growth cone collapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418885">
<property type="pathway name" value="DCC mediated attractive signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418886">
<property type="pathway name" value="Netrin mediated repulsion signals"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663213">
<property type="pathway name" value="RHO GTPases Activate WASPs and WAVEs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8874081">
<property type="pathway name" value="MET activates PTK2 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q05397"/>
<dbReference type="SIGNOR" id="Q05397"/>
<dbReference type="ChiTaRS" id="PTK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q05397"/>
<dbReference type="GeneWiki" id="PTK2"/>
<dbReference type="GenomeRNAi" id="5747"/>
<dbReference type="PMAP-CutDB" id="Q05397"/>
<dbReference type="PRO" id="PR:Q05397"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000169398"/>
<dbReference type="CleanEx" id="HS_PTK2"/>
<dbReference type="ExpressionAtlas" id="Q05397">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q05397">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005815">
<property type="term" value="C:microtubule organizing center"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001725">
<property type="term" value="C:stress fiber"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008432">
<property type="term" value="F:JUN kinase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048870">
<property type="term" value="P:cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021955">
<property type="term" value="P:central nervous system neuron axonogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009790">
<property type="term" value="P:embryo development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043542">
<property type="term" value="P:endothelial cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048013">
<property type="term" value="P:ephrin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030010">
<property type="term" value="P:establishment of cell polarity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040023">
<property type="term" value="P:establishment of nucleus localization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097194">
<property type="term" value="P:execution phase of apoptosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060396">
<property type="term" value="P:growth hormone receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003007">
<property type="term" value="P:heart morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000226">
<property type="term" value="P:microtubule cytoskeleton organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000811">
<property type="term" value="P:negative regulation of anoikis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050771">
<property type="term" value="P:negative regulation of axonogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0022408">
<property type="term" value="P:negative regulation of cell-cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046621">
<property type="term" value="P:negative regulation of organ growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051964">
<property type="term" value="P:negative regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038007">
<property type="term" value="P:netrin-activated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001764">
<property type="term" value="P:neuron migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001890">
<property type="term" value="P:placenta development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045860">
<property type="term" value="P:positive regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000060">
<property type="term" value="P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033628">
<property type="term" value="P:regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008360">
<property type="term" value="P:regulation of cell shape"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051493">
<property type="term" value="P:regulation of cytoskeleton organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010594">
<property type="term" value="P:regulation of endothelial cell migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010632">
<property type="term" value="P:regulation of epithelial cell migration"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051893">
<property type="term" value="P:regulation of focal adhesion assembly"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043087">
<property type="term" value="P:regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045667">
<property type="term" value="P:regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001932">
<property type="term" value="P:regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900024">
<property type="term" value="P:regulation of substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007172">
<property type="term" value="P:signal complex assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001570">
<property type="term" value="P:vasculogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.80.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR019749">
<property type="entry name" value="Band_41_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR014352">
<property type="entry name" value="FERM/acyl-CoA-bd_prot_3-hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR019748">
<property type="entry name" value="FERM_central"/>
</dbReference>
<dbReference type="InterPro" id="IPR000299">
<property type="entry name" value="FERM_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR005189">
<property type="entry name" value="Focal_adhesion_kin_target_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH_dom-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-rel_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00373">
<property type="entry name" value="FERM_M"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03623">
<property type="entry name" value="Focal_AT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="ProDom" id="PD006413">
<property type="entry name" value="Focal_adhesion_target_reg"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00295">
<property type="entry name" value="B41"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47031">
<property type="entry name" value="SSF47031"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50729">
<property type="entry name" value="SSF50729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF68993">
<property type="entry name" value="SSF68993"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00661">
<property type="entry name" value="FERM_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50057">
<property type="entry name" value="FERM_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="10 11 67">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Focal adhesion kinase 1" id="PRO_0000088077">
<location>
<begin position="2"/>
<end position="1052"/>
</location>
</feature>
<feature type="domain" description="FERM" evidence="16">
<location>
<begin position="35"/>
<end position="355"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="17">
<location>
<begin position="422"/>
<end position="680"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="17 24">
<location>
<begin position="428"/>
<end position="434"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="17 24">
<location>
<begin position="500"/>
<end position="502"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TGFB1I1">
<location>
<begin position="707"/>
<end position="1052"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ARHGEF28" evidence="14">
<location>
<begin position="912"/>
<end position="1052"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="712"/>
<end position="733"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="863"/>
<end position="913"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="17 18">
<location>
<position position="546"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="17 24">
<location>
<position position="454"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="10 11 67">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="5"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 10 13">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 13">
<location>
<position position="29"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="54"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10 23 27 34 35 37 50">
<location>
<position position="397"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="23 27">
<location>
<position position="407"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="570"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by RET and SRC" evidence="27 50 59">
<location>
<position position="576"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by RET and SRC" evidence="23 50 59">
<location>
<position position="577"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="580"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="50">
<location>
<position position="722"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5" evidence="14">
<location>
<position position="732"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="843"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="23 37 50">
<location>
<position position="861"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="887"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 10 12 13">
<location>
<position position="910"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12">
<location>
<position position="914"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="23 50">
<location>
<position position="925"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="14">
<location>
<position position="152"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_042168" evidence="71">
<location>
<begin position="1"/>
<end position="692"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 4." id="VSP_004967" evidence="70">
<location>
<begin position="1"/>
<end position="181"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 4." id="VSP_004968" evidence="70">
<original>EMRGNALE</original>
<variation>MSDYWVVG</variation>
<location>
<begin position="182"/>
<end position="189"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 4." id="VSP_004969" evidence="70">
<original>A</original>
<variation>ACHYTSLHWNWCRYISDPNVDACPDPRNAE</variation>
<location>
<position position="472"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_004971" evidence="70">
<original>ASKGK</original>
<variation>GKKSG</variation>
<location>
<begin position="579"/>
<end position="583"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_004972" evidence="70">
<location>
<begin position="584"/>
<end position="1052"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_004973" evidence="70">
<original>STILEEEKAQQEERMRMESRRQATVSWDSG</original>
<variation>FQNPAQMLPASGRLPNQPCPERENYSFATF</variation>
<location>
<begin position="677"/>
<end position="706"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_004974" evidence="70">
<location>
<begin position="707"/>
<end position="1052"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_057268" evidence="69">
<location>
<begin position="744"/>
<end position="789"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004970" evidence="70">
<location>
<begin position="834"/>
<end position="854"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_042169" evidence="68">
<original>D</original>
<variation>GKEEKNWAERN</variation>
<location>
<position position="868"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_042170" evidence="68">
<original>K</original>
<variation>KPWR</variation>
<location>
<position position="903"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_041682" evidence="33">
<original>H</original>
<variation>P</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_041683" evidence="33">
<original>H</original>
<variation>Q</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioblastoma multiforme sample; somatic mutation." id="VAR_041684" evidence="33">
<original>V</original>
<variation>A</variation>
<location>
<position position="793"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_041685" evidence="33">
<original>D</original>
<variation>E</variation>
<location>
<position position="1030"/>
</location>
</feature>
<feature type="sequence variant" description="In a metastatic melanoma sample; somatic mutation." id="VAR_041686" evidence="33">
<original>K</original>
<variation>E</variation>
<location>
<position position="1044"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation. Abolishes interaction with SRC and activation of BMX." evidence="20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with TGFB1I1." evidence="66">
<original>V</original>
<variation>G</variation>
<location>
<position position="928"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with TGFB1I1." evidence="66">
<original>L</original>
<variation>S</variation>
<location>
<position position="1034"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG65198." ref="3" evidence="71">
<original>R</original>
<variation>L</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG65198." ref="3" evidence="71">
<original>L</original>
<variation>I</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA35819." ref="2" evidence="71">
<original>P</original>
<variation>S</variation>
<location>
<position position="778"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="49"/>
<end position="51"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="53"/>
<end position="58"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="64"/>
<end position="73"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="74"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="83"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="95"/>
<end position="98"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="104"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="117"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="120"/>
<end position="126"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="133"/>
<end position="137"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="141"/>
<end position="158"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="165"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="185"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="191"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="197"/>
<end position="201"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="209"/>
<end position="214"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="220"/>
<end position="228"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="229"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="236"/>
<end position="247"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="248"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="256"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="268"/>
<end position="275"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="279"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="290"/>
<end position="294"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="299"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="308"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="314"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="327"/>
<end position="333"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="334"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="413"/>
<end position="415"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="422"/>
<end position="430"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="432"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="444"/>
<end position="446"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="448"/>
<end position="455"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="457"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="462"/>
<end position="468"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="470"/>
<end position="476"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="486"/>
<end position="490"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="492"/>
<end position="494"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="496"/>
<end position="500"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="507"/>
<end position="513"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="514"/>
<end position="517"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="520"/>
<end position="539"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="549"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="552"/>
<end position="556"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="559"/>
<end position="562"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="565"/>
<end position="568"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="570"/>
<end position="573"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="574"/>
<end position="576"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="586"/>
<end position="588"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="591"/>
<end position="596"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="601"/>
<end position="616"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="617"/>
<end position="619"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="622"/>
<end position="625"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="628"/>
<end position="630"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="631"/>
<end position="636"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="649"/>
<end position="658"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="663"/>
<end position="665"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="669"/>
<end position="684"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="685"/>
<end position="687"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="915"/>
<end position="917"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="923"/>
<end position="942"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="947"/>
<end position="949"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="950"/>
<end position="971"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="972"/>
<end position="974"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="977"/>
<end position="979"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="980"/>
<end position="1006"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1007"/>
<end position="1009"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1010"/>
<end position="1012"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1013"/>
<end position="1045"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1K04"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IJM"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EBV"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GU6"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I4E"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4K9Y"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4NY0"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250"/>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P34152"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00084"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10655584"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11331870"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11980671"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12221124"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12387730"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12467573"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14527389"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15166238"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15561106"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15855171"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15895076"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16452200"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16919435"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16927379"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17395594"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17431114"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17968709"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18006843"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18078954"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18206965"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18256281"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18292575"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18339875"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18497331"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18657504"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18677107"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19118217"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19138410"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19147981"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19224453"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19339212"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19494199"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19787193"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19917054"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20037584"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20109444"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20332118"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20439989"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20495381"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454698"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23503467"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23509069"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7692878"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8247543"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8422239"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9422762"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9756887"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="68" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8422239"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000305"/>
<sequence length="1052" mass="119233" checksum="D8A4C15138AB0243" modified="1998-07-15" version="2">
MAAAYLDPNLNHTPNSSTKTHLGTGMERSPGAMERVLKVFHYFESNSEPTTWASIIRHGD
ATDVRGIIQKIVDSHKVKHVACYGFRLSHLRSEEVHWLHVDMGVSSVREKYELAHPPEEW
KYELRIRYLPKGFLNQFTEDKPTLNFFYQQVKSDYMLEIADQVDQEIALKLGCLEIRRSY
WEMRGNALEKKSNYEVLEKDVGLKRFFPKSLLDSVKAKTLRKLIQQTFRQFANLNREESI
LKFFEILSPVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGCNPTHLADFTQVQ
TIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGTSQSFII
RPQKEGERALPSIPKLANSEKQGMRTHAVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRE
RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH
PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK
RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT
SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA
YDPSRRPRFTELKAQLSTILEEEKAQQEERMRMESRRQATVSWDSGGSDEAPPKPSRPGY
PSPRSSEGFYPSPQHMVQTNHYQVSGYPGSHGITAMAGSIYPGQASLLDQTDSWNHRPQE
IAMWQPNVEDSTVLDLRGIGQVLPTHLMEERLIRQQQEMEEDQRWLEKEERFLKPDVRLS
RGSIDREDGSLQGPIGNQHIYQPVGKPDPAAPPKKPPRPGAPGHLGSLASLSSPADSYNE
GVKLQPQEISPPPTANLDRSNDKVYENVTGLVKAVIEMSSKIQPAPPEEYVPMVKEVGLA
LRTLLATVDETIPLLPASTHREIEMAQKLLNSDLGELINKMKLAQQYVMTSLQQEYKKQM
LTAAHALAVDAKNLLDVIDQARLKMLGQTRPH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>